ASRS 2019 Street Team: Josh Anderson

Conference|ASRS

Josh Anderson, head of Alcon's U.S. Surgical Retina Sales & Marketing, discusses how the NGENUITY 3D Visualization System creates an immersive surgical experience. 

Related Videos
DAVIO trial update: 12-month safety results indicate no serious adverse events, reduced treatment burden
Phase 4 Paladin finds fluocinolone to be safe, effective in patients with diabetic macular edema
Foundation Fighting Blindness: Building a toolbox of therapies for dry AMD, inherited retinal diseases
Faricimab for DME: Personalized treatment interval dosing maintains visual acuity, reduces treatment burden
Diabetic retinopathy eye drop: Phase 1B clinical results show promise
Quicker time to surgery affects VA outcomes in macula-on rhegmatogenous retinal detachments
Giant retinal tear-related detachments: Pediatric eyes repair better after vitrectomy with scleral buckling; adults only need vitrectomy
KALAHARI study: Phase 2 early results indicate alternative treatment pathway for patients with DME is effective, durable
Elevated albumin to creatinine ratio associated with central subfield thickness fluctuations in patients with DME
RGX-314 demonstrates DRSS improvements in patients with DME, NPDR
Related Content

ASRS 2022 recap: Significant strides in DME, AMD discussed among retina specialists

July 18th 2022

Putting in practice retina innovations amid a pandemic

August 28th 2020

New tool emerges for predicting the risk of vision loss from diabetic retinopathy

July 15th 2022

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

July 29th 2020

TOWER study: A new index to measure retinal fluid fluctuations in the retina in wet AMD

July 15th 2022

Pediatric retinal detachment surgery in the US: Primary scleral buckling achieved best visual acuity

July 14th 2022

ASRS 2022 recap: Significant strides in DME, AMD discussed among retina specialists

July 18th 2022

Putting in practice retina innovations amid a pandemic

August 28th 2020

New tool emerges for predicting the risk of vision loss from diabetic retinopathy

July 15th 2022

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

July 29th 2020

TOWER study: A new index to measure retinal fluid fluctuations in the retina in wet AMD

July 15th 2022

Pediatric retinal detachment surgery in the US: Primary scleral buckling achieved best visual acuity

July 14th 2022

ASRS 2022 recap: Significant strides in DME, AMD discussed among retina specialists

July 18th 2022

Putting in practice retina innovations amid a pandemic

August 28th 2020

New tool emerges for predicting the risk of vision loss from diabetic retinopathy

July 15th 2022

ASRS 2020: Evaluating 3-year-recurrence rate in non-infectious posterior segment uveitis post-FAi

July 29th 2020

TOWER study: A new index to measure retinal fluid fluctuations in the retina in wet AMD

July 15th 2022

Pediatric retinal detachment surgery in the US: Primary scleral buckling achieved best visual acuity

July 14th 2022
© 2023 MJH Life Sciences

All rights reserved.